2026-10-10T17:59:37Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34046671 2026-10-01T15:40:04Z category_37339 category_37363 category_37366 portal_1012 item_type_3 month_year_10_2026

Table 5 from A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers Marwan Fakih (20887297) Toshihiko Doi (15023340) Anthony Tolcher (15360073) David Hong (25157236) Jeanne Tie (15021428) Wells Messersmith (25157239) Takafumi Koyama (15035714) Lee Rosen (25157242) Joana Borlido (25157245) Michael A. Damore (25157248) Maria Delioukina (21718583) Ioanna Cheronis (25157251) Lee Noel Clark (25157254) Marzieh Golmakani (25157257) Amy Jackson-Fisher (21644204) Szu-Yu Tang (25157260) Cathy Cen Guo (25157263) Edmund J. Keliher (25157266) Kevin Maresca (21644261) Neil H. Segal (15024324) Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Gastrointestinal Cancers Immunotherapy Phase I Clinical Trials <p>Descriptive summary of serum PF-07062119 PK parameters (without priming dose) for cycle 1.</p> 2026-10-01T00:00:00Z Dataset Dataset 10.1158/2767-9764.34046671 https://figshare.com/articles/dataset/Table_5_from_A_Phase_I_Study_of_PF-07062119_an_Anti-GUCY2C_Anti-CD3_Bispecific_Fc_Antibody_in_Patients_with_Advanced_Gastrointestinal_Cancers/34046671 CC BY